Literature DB >> 19401392

IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.

L Giordani1, M Sanchez, I Libri, M G Quaranta, B Mattioli, M Viora.   

Abstract

TLRs are a family of molecules that function as sensors for the detection of pathogens. TLR-9, expressed on B cells and pDCs, recognizes CpG motifs of unmethylated bacterial DNA and plays a role in the development of autoimmunity. The present study was designed to investigate the effects of IFN-alpha in combination with CpG ODN on the activation of CD27(-) naïve B cells and on Ig production. We provide evidence that CpG ODN not only induces a total and T-dependent, specific IgM response by naïve B cells but also their phenotypic differentiation in plasma cells, as demonstrated by the up-regulation of CD38 expression. We found that TLR-9 stimulation with CpG ODN induces IL-1beta, TNF-alpha, IL-10, and IL-6 production. Interestingly, we also found that CpG ODN induces naïve B cell maturation into memory cells, as demonstrated by the induction of CD27, AID mRNA expression, and IgG production. More importantly, our results demonstrate that IFN-alpha amplifies the inductive effect of CpG ODN on naïve B activation and on Ig production through a mechanism involving TLR-9/MyD88-dependent signaling. Moreover, we found that IFN-alpha enhances the frequency of CpG ODN-induced memory B cells. Our results may contribute to clarify the events promoting IFN-alpha-induced amplification of naïve B cell activation via TLR-9 for a better understanding of the pathogenesis of autoimmune disorders and may guide treatments targeting this pathway within B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401392     DOI: 10.1189/jlb.0908560

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  22 in total

Review 1.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

Review 2.  Toll-like receptor signaling in primary immune deficiencies.

Authors:  Paul J Maglione; Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2015-04-30       Impact factor: 5.691

3.  Negative regulation of inflammatory responses by immunoglobulin A receptor (FcαRI) inhibits the development of Toll-like receptor-9 signalling-accelerated glomerulonephritis.

Authors:  T Watanabe; Y Kanamaru; C Liu; Y Suzuki; N Tada; K Okumura; S Horikoshi; Y Tomino
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

4.  TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.

Authors:  Noa Simchoni; Charlotte Cunningham-Rundles
Journal:  J Immunol       Date:  2015-03-04       Impact factor: 5.422

5.  Polyclonal B cell activation for accurate analysis of pre-existing antigen-specific memory B cells.

Authors:  G E Karahan; M Eikmans; J D H Anholts; F H J Claas; S Heidt
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.

Authors:  H Travis Ichikawa; Thomas Conley; Tony Muchamuel; Jing Jiang; Susan Lee; Teresa Owen; Jennifer Barnard; Sarah Nevarez; Bruce I Goldman; Christopher J Kirk; R John Looney; Jennifer H Anolik
Journal:  Arthritis Rheum       Date:  2012-02

Review 7.  Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases.

Authors:  Akbar Mohammad Hosseini; Jafar Majidi; Behzad Baradaran; Mehdi Yousefi
Journal:  Adv Pharm Bull       Date:  2015-12-31

8.  Role of microRNA-15a in autoantibody production in interferon-augmented murine model of lupus.

Authors:  Yao Yuan; Siddha Kasar; Chingiz Underbayev; Daniel Vollenweider; Erica Salerno; Sergei V Kotenko; Elizabeth Raveche
Journal:  Mol Immunol       Date:  2012-05-11       Impact factor: 4.407

Review 9.  Toll-like receptor function in primary B cell defects.

Authors:  Thomas U Marron; Joyce E Yu; Charlotte Cunningham-Rundles
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

10.  Synergistic induction of interferon α through TLR-3 and TLR-9 agonists identifies CD21 as interferon α receptor for the B cell response.

Authors:  Dhohyung Kim; Stefan Niewiesk
Journal:  PLoS Pathog       Date:  2013-03-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.